Viatris (VTRS) , a global healthcare company, is scheduled to report first-quarter results on May 9, 2024. The company’s earnings beat estimates in three of the trailing four quarters and missed in one, delivering an average surprise of 3.78%. In the last reported quarter, the company missed on earnings by 8.96%. Factors to Consider Viatris reports revenues under two divisions in terms of product category —brands and generics. Brand business makes up about two-thirds of the company’s portfolio. This categor ...